Taiwan FDA registration 59ddb5d8b805e0a289a32bc3fe72737d
Cefudine-HIV 1/2
TW: 賽富定-HIV 1/2
Taiwan·Risk Class 3·FUJIREBIO INC., HACHIOJI FACILITY·Registered Oct 11, 2005 – Nov 23, 2025ExpiredRegistration details
- Analysis ID
- 59ddb5d8b805e0a289a32bc3fe72737d
- Customs Code
- DHA00601316704
Company information
- Manufacturer
- FUJIREBIO INC., HACHIOJI FACILITY
- Manufacturer Country
- Japan
- Authorized Representative
- Grand Marquis IVD CO., LTD.
Product details
- Intended Use
- Particle agglutination test for anti-HIV 1/2 in human serum or plasma for screening.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Import Information
- import
Dates and status
- Registration Date
- Oct 11, 2005
- Expiry Date
- Nov 23, 2025
About this record
Access comprehensive regulatory information for Cefudine-HIV 1/2 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 59ddb5d8b805e0a289a32bc3fe72737d and manufactured by FUJIREBIO INC., HACHIOJI FACILITY. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices